Showing 261 - 280 results of 832 for search '"Neisseria meningitidis"', query time: 0.09s Refine Results
  1. 261

    Experimentally revised repertoire of putative contingency loci in Neisseria meningitidis strain MC58: evidence for a novel mechanism of phase variation. by Martin, P, van de Ven, T, Mouchel, N, Jeffries, A, Hood, D, Moxon, E

    Published 2003
    “…Analysis of the genome sequence of Neisseria meningitidis strain MC58 revealed 65 genes associated with simple sequence repeats. …”
    Journal article
  2. 262

    Application of a Neisseria meningitidis antigen microarray to identify candidate vaccine proteins from a human Phase I clinical trial by Chang, C-M, Awanye, AM, Marsay, L, Dold, C, Pollard, AJ, Rollier, CS, Feavers, IM, Maiden, MCJ, Derrick, JP

    Published 2022
    “…Outer membrane vesicles (OMV) from Neisseria meningitidis have been used successfully as vaccines against the disease, although they only provide protection against a limited number of the many existing variants. …”
    Journal article
  3. 263

    Molecular typing methods for outbreak detection and surveillance of invasive disease caused by Neisseria meningitidis, Haemophilus influenzae and Streptococcus pneumoniae, a review by Harrison, O, Brueggemann, A, Caugant, D, van der Ende, A, Frosch, M, Gray, S, Heuberger, S, Krizova, P, Olcen, P, Slack, M, Taha, M, Maiden, M

    Published 2011
    “…Invasive disease caused by the encapsulated bacteria <em>Neisseria meningitidis</em>, <em>Haemophilus influenzae</em> and <em>Streptococcus pneumoniae</em> remains an important cause of morbidity and mortality worldwide, despite the introduction of successful conjugate polysaccharide vaccines that target disease-associated strains. …”
    Journal article
  4. 264
  5. 265
  6. 266
  7. 267
  8. 268
  9. 269
  10. 270
  11. 271
  12. 272

    Use of sodC versus ctrA for real-time polymerase chain reaction-based detection of Neisseria meningitidis in sterile body fluids by Fábio Takenori Higa, Lucila Okuyama Fukasawa, Maria Gisele Gonçalves, Maristela Marques Salgado, Ana Paula Silva de Lemos, Lee H Harrison, Priscilla Lima de Oliveira, Carla Naufal da Silva, Claudio Tavares Sacchi

    Published 2013-04-01
    “…We evaluated the use of a newly described sodC-based real-time-polymerase chain reaction (RT-PCR) assay for detecting Neisseria meningitidis in normally sterile sites, such as cerebrospinal fluid and serum. …”
    Get full text
    Article
  13. 273
  14. 274
  15. 275
  16. 276

    Whole genome analysis of Neisseria meningitidis isolates from invasive meningococcal disease collected in the Czech Republic over 28 years (1993-2020). by Michal Honskus, Pavla Krizova, Zuzana Okonji, Martin Musilek, Jana Kozakova

    Published 2023-01-01
    “…The aim of this study was to define the clonal composition of the Neisseria meningitidis population in the Czech Republic, to determine changes in this population over time and to estimate the theoretical coverage of isolates by MenB vaccines. …”
    Get full text
    Article
  17. 277

    A new combination haemophilus influenzae type B and Neisseria meningitidis serogroup C-tetanus toxoid conjugate vaccine for primary immunization of infants. by Pace, D, Snape, M, Westcar, S, Hamaluba, M, Yu, L, Begg, N, Wysocki, J, Czajka, H, Maechler, G, Boutriau, D, Pollard, A

    Published 2007
    “…We conducted a phase 3 randomized controlled trial looking at the immunogenicity and safety of a novel combined Haemophilus influenzae type b and Neisseria meningitidis serogroup C tetanus toxoid conjugate vaccine, Hib-MenC-TT in a 2-, 3-, and 4-month primary infant immunization schedule. …”
    Journal article
  18. 278
  19. 279
  20. 280

    Two cross-reactive monoclonal antibodies recognize overlapping epitopes on Neisseria meningitidis factor H binding protein but have different functional properties. by Faleri, A, Santini, L, Brier, S, Pansegrau, W, Lo Surdo, P, Scarselli, M, Buricchi, F, Volpini, G, Genovese, A, van der Veen, S, Lea, S, Tang, C, Savino, S, Pizza, M, Finco, O, Norais, N, Masignani, V

    Published 2014
    “…Factor H binding protein (fHbp) is one of the main antigens of the 4-component meningococcus B (4CMenB) multicomponent vaccine against disease caused by serogroup B Neisseria meningitidis (MenB). fHbp binds the complement down-regulating protein human factor H (hfH), thus resulting in immune evasion. fHbp exists in 3 variant groups with limited cross-protective responses. …”
    Journal article